AKT1 and neoplasm: FABP5 enhances tumour cell proliferation and migration via pathways including PI3K/AKT/mTOR and cAMP response element-binding protein (CREB)-mediated miR-889-5p signalling, which targets and suppresses the tumour suppressor Kruppel-like factor 9 (KLF9) [121].